Construction and application of symptom management program for multiple myeloma patients during treatment based on SMT

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300067715

Enrollment

Unknown

Registered

2023-01-19

Start date

2023-01-19

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple myeloma

Interventions

experimental group:Intervention based on symptom management theory

control group:usual care

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years; 2. Chemotherapy, cellular immunotherapy, targeted therapy in the research hospital, with follow-up conditions; 3. If his condition permits, he may exercise regularly; Good understanding and communication skills; 4. A patient with a primary pathological diagnosis of multiple myeloma.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of other cancers; 2. Patients who participated in other symptom management programs were excluded.

Design outcomes

Primary

Measure	Time frame
Quality of life;	—

Secondary

Measure	Time frame
Fatigue;Pain;Quality of sleep;	—

Countries

China

Contacts

Public ContactChu Hong

Nanjing Drum Tower Hospital

chuhong81@163.com+86 13851487794

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026